Publications by authors named "Marion Gillibert-Yvert"

Claim this Profile
L
Long-term follow-up of children with risk organ-negative Langerhans cell histiocytosis after 2-chlorodeoxyadenosine treatment.
Mohamed-Aziz Barkaoui, Emma Queheille, Nathalie Aladjidi, Geneviève Plat, Eric Jeziorski, Marion Gillibert-Yvert

Br J Haematol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence and risk factors for clinical neurodegenerative Langerhans cell histiocytosis: a longitudinal cohort study.
Sébastien Héritier, Mohamed-Aziz Barkaoui, Jean Miron, Caroline Thomas, Despina Moshous, Marion Gillibert-Yvert

Br J Haematol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating cell-free BRAF as a biomarker in children with Langerhans cell histiocytosis.
Sébastien Héritier, Zofia Hélias-Rodzewicz, Hélène Lapillonne, Nathalie Terrones, Sonia Garrigou, Marion Gillibert-Yvert

Br J Haematol· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BRAF Mutation Correlates With High-Risk Langerhans Cell Histiocytosis and Increased Resistance to First-Line Therapy.
Sébastien Héritier, Jean-François Emile, Mohamed-Aziz Barkaoui, Caroline Thomas, Sylvie Fraitag, Marion Gillibert-Yvert

J Clin Oncol· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retrospective French nationwide survey of childhood aggressive vascular anomalies of bone, 1988-2009.
Sébastien Héritier, Martine Le Merrer, Francis Jaubert, Michèle Bigorre, Marion Gillibert-Yvert

Orphanet J Rare Dis· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis